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Communication During Pediatric Asthma Visits and
Self-Reported Asthma Medication Adherence
WHAT’S KNOWN ON THIS SUBJECT: Little is known about how
communication during pediatric asthma visits is associated with
child control medication adherence 1 month after the visit.
WHAT THIS STUDY ADDS: When providers asked for caregiver
input into the asthma treatment plan during the visit, caregivers
reported significantly higher child medication adherence to
control medications 1 month later.
abstract
OBJECTIVE: Our objectives were to examine how certain aspects of
provider-patient communication recommended by national asthma
guidelines (ie, provider asking for child and caregiver input into the
asthma treatment plan) were associated with child asthma
medication adherence 1 month after an audio-taped medical visit.
METHODS: Children ages 8 through 16 with mild, moderate, or se-
vere persistent asthma and their caregivers were recruited at 5 pe-
diatric practices in nonurban areas of North Carolina. All medical
visits were audio-tape recorded. Children were interviewed 1 month
after their medical visits, and both children and caregivers reported
the child’s control medication adherence. Generalized estimating
equations were used to determine if communication during the
medical visit was associated with medication adherence 1 month
later.
RESULTS: Children (n = 259) completed a home visit interview ∼1
month after their audio-taped visit, and 216 of these children were
taking an asthma control medication at the time of the home visit.
Children reported an average control medication adherence for the
past week of 72%, whereas caregivers reported the child’s average
control medication adherence for the past week was 85%. Child
asthma management self-efficacy was significantly associated with
both child- and caregiver-reported control medication adherence.
When providers asked for caregiver input into the asthma treatment
plan, caregivers reported significantly higher child medication
adherence 1 month later.
CONCLUSIONS: Providers should ask for caregiver input into their
child’s asthma treatment plan because it may lead to better control
medication adherence. Pediatrics 2012;130:627–633
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ARTICLE
Asthma is the most common chronic
condition among US children.1,2 In the
United States, asthma affects.6 million
children and accounts for an estimated
20 billion dollars in health care costs
annually.3 The clinical practice guidelines
of the National Asthma Education and
Prevention Program of the National
Heart Lung and Blood Institute encour-
age physicians to discuss medications
with patients at every follow-up asthma
visit.3 The guidelines also emphasize the
importance of jointly determining the
goals of treatment with the patient and
family.3 Moreover, the 2001 US Institute
of Medicine report endorsed patient-
centered care and recommended that
health care professionals implement the
shared decision-making (SDM) model in
clinical settings.4,5
More recently, the concept of “patient-
centered” approaches have been in-
troduced as an effective way to involve
and motivate the patient. In a study of
adult asthma patients, a SDM approach
was compared with traditional clini-
cian decision-making. It was found that
the SDM intervention resulted in better
adherence to controller medications
and better clinical outcomes.6
However, little is known about the re-
lationship between provider-patient
communication during pediatric asthma
visits and its associationwith child- and
caregiver-reported control medication
adherence.7,8 Apter et al7 found that
poor patient ratings of patient-provider
communication about asthma were
related to poor adherence to inhaled
steroids. Chambers et al8 discovered
that regular inhaled corticosteroid use
was related to whether patients per-
ceived themselves as actively involved
in treatment decisions during medical
visits. A limitation of these previous
studies is that they relied on subjective
patient reports of medical visit com-
munication rather than objective data,
such as audio-tape recordings of the
visits.7,8
Our previous work demonstrated that
providers rarely asked for child or
caregiver input into the child’s asthma
treatment plan during audio-taped pe-
diatric medical visits.9 This current
article examines how certain as-
pects of provider-patient communica-
tion that are recommended by the
national asthma guidelines (ie, number
of control medication questions the
provider asks, the total number of
medication questions asked by chil-
dren, and the provider asking for child
and caregiver input into the asthma
treatment plan) are associated with
child asthma medication adherence 1
month after the audio-taped visit.
METHODS
Participants
The study was approved by the Univer-
sity of North Carolina Institutional Re-
view Board. Providers were recruited at
5 pediatric practices in North Carolina,
andconsentwasobtained.Theproviders
were told that the study focused on
communicationduringpediatricasthma
visits. Children and their caregivers of
these participating providers were re-
cruited. Children were eligible if they (1)
were ages 8 through 16 years, (2) were
able to speak English, (3) could read the
assent form, (4) had been seen at the
clinic at least once before, (5) were
present at the visit with an adult care-
giver (parent or legal guardian) who
could read and speak English and who
was at least 18 years of age, and (6) had
mild, moderate, or severe persistent
asthma. Persistent asthma was defined
as experiencing asthma-relateddaytime
symptoms more than twice a week,
asthma-related nighttime symptoms
more than twice amonth, or receiving 1
ormore long-term controller therapies
for asthma.7,8
Clinic staff referred potentially eligible
patients who were interested in learn-
ing more about the study to a re-
searchassistant. The researchassistant
explained the study, obtained caregiver
consent and child assent, and adminis-
tered the eligibility screener.9 Providers
and families were told that the study
was examining communication during
pediatric visits. All of the medical visits
were audio-tape recorded. A home visit
was conducted 1 month later, during




Each medical visit audio-tape was
transcribed verbatim and then coded
by 2 research assistants. To assist with
coding asthma-related communication,
the research assistants used a detailed
coding tool that contained code defi-
nitions and example quotations. The 2
research assistants coded 20 of the
same transcripts throughout the study
period to assess intercoder reliability.
More detail about how the communi-
cation variableswere coded is provided




The caregiver screening instrument
assessed children’s medication use.
The research assistants showed care-
givers a list of asthmamedications and
asked them to indicate which one(s)
the child was taking. Responses were
dichotomized based on whether the
caregiver reported that the child was
taking a controller medication versus
not taking a controller medication.
Using data from the study’s eligibility
screening instrument, asthma sever-
ity was classified as mild versus
moderate/severe by a research assis-
tant based on the caregiver’s report of
the child’s recent symptoms and med-
ication use.7–9 Our eligibility screening
instrument used the primary asthma
severity classification system that was
in use when the study was designed
628 SLEATH et al
and conducted.7–9 More detail about
the asthma severity classification sys-
tem is provided by Sleath et al.9
A variety of demographic and socio-
cultural factors were examined as
potential confounders. For descrip-
tive purposes, child self-reported race
was re-coded into 4 categories: white,
African American, Native American/
American Indian, or other. However,
for the bivariate and multivariable
analyses, child race was re-coded into
a dichotomous variable (white versus
nonwhite). The child’s insurance status,
which was reported by the caregivers,
was measured by using the following
categories: none, private insurance,
Medicaid, the State Children’s Health
Insurance Program, and other. Care-
givers also reported the number of
years the child had asthma, which was
measured as a continuous variable
and the number of control medications
the child was taking at the home visit.
Due to skewness of the data, for the
multivariable analysis, number of con-
trol medications was recoded into 1 vs
2 or more control medications.
Caregiver self-reported education was
measured in years. Child-reported
asthma management self-efficacy was
measured at the home visit by using
a 14-item scale (a = .87).10 We calcu-
lated the mean asthma management
self-efficacy score as a continuous
measure for each child; higher scores
indicate greater self-efficacy. Child-
reported outcome expectations for
asthma medications was measured as
a continuous variable by using an
adapted version of Holden’s 5-item
outcome expectations scale.11 The
scale had a reliability of 0.64, and
higher scores represent more positive
outcome expectations for asthma
medicines. We calculated the mean
outcomes expectations score as a con-
tinuous measure for each child. Length
of the medical visits was measured in
seconds.
Communication During Visits
The coders also recorded the numberof
medicationquestionsaskedby the child,
whether the provider included child in-
put into the asthma management
treatment plan, whether the provider
includedcaregiver input into theasthma
management treatment plan, and the
number of questions the provider asked
about control medications.
Two research assistants coded 20 of the
same transcripts throughout the study
period to assess intercoder reliability.
Interrater reliability varied between
0.88 and 1.0 for the following commu-
nication variables: (1) the total number
of medication questions asked by chil-
drenwas 0.96, (2) whether the provider
asked for child input into the asthma
management treatment plan was 0.88,
(3) whether the provider asked for
caregiver input into the asthma man-
agement treatment plan was 1.0, and
(4) the number of provider questions
about control medications was 0.95.
Child’s Control Medication Adherence
Child and caregiver reports of the child’s
medication adherence was measured by
using the Brief Medication Question-
naire, which was developed by Svarstad
et al.12 Child and caregiver reports of the
child’s adherence were calculated by
using the following formula: adherence =
(number of doses reported using during
the past week divided by the number of
prescribed doses) multiplied by 100. If
the child was taking .1 control medi-
cation, an overall percent adherence
variable was created by adding together
the reported adherence for each control
medication and dividing it by the number
of control medications the child was us-
ing. Adherence data were collected at
both the office visit and home visit.
Statistical Analyses
All analyses were conducted by using
SPSS (SPSS Inc, Chicago, IL). First, we
present descriptive statistics for all of
the variables. Second, we examine bi-
variate relationships between the var-
iables by using correlation coefficients,
t tests, or Pearson x2 statistics. Only
children who completed a home visit
and who were taking at least 1 control
medication were included in the ad-
herence analyses (N = 216).
Next, we used generalized estimating
equations (GEEs) to predict the follow-
ing: (1) the child’s self-reported ad-
herence for the past week at the home
visit and (2) the caregiver’s report of
the child’s adherence for the past week
at the home visit. We controlled for the
following variables because they have
been associated with medication ad-
herence in previous studies: child age,
gender, race, years with asthma, se-
verity of asthma, caregiver education,
child self-efficacy, and child outcome
expectations. Additionally, for the child
model, we controlled for the child’s
medication adherence at the office visit,
and for the caregiver model, we con-
trolled for the caregiver’s report of the
child’s medication adherence at the of-
fice visit. Each GEE also included 4 com-
munication variables: (1) the number of
medication questions asked by the child,
(2) whether the provider asked for child
input into the asthma management
treatment plan, (3) whether the provider
asked for caregiver input into the
asthma management treatment plan,
and (4) the number of questions the
providerasks about controlmedications.
RESULTS
The 5 participating clinics were pri-
mary care pediatric practices. Forty-
one providers agreed to participate in
the study. Two providers refused to
participate for a participation rate of
95.3%. Eighty-eight percent of the fam-
ilies approached agreed to participate
in the study. Two hundred ninety-six
patients had useable audio-tape data,
and these patients were seen by 35
of the 41 providers who agreed to
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participate in the study. Four of the 35
providers were nurse practitioners or
physician assistants, and they saw17 of
the participating children. Fifty-one
percent of the providers were women.
Twenty-seven of the providers were
white, 2 were American Indian, 3 were
African American, 1 was Asian, and 2
classified their race as other. Providers
rangedinagefrom30to70years(mean=
44.8 years, SD = 9.4).
Thecurrent article focuseson the 259of
296 children (88%) who completed
a home visit interview ∼1 month after
their audio-taped medical visit. Table 1
presents the child and caregiver de-
mographic characteristics. Child age
ranged from 8 to 16 years (mean age =
11.1 years, SD = 2.4). Approximately
30% of the sample was African Ameri-
can; 50.6% of the sample was male.
Seventy-one percent of the children
hadmoderate/severe persistent asthma.
Child self-efficacy scores ranged from 2
to 5 (mean = 4.05, SD = 0.62). Child
outcome expectation scores ranged
from 3.6 to 9 (mean = 7.9, SD = 1.1).
Eighty-three percent of the children
were taking 1 or more control medi-
cations (N = 216).
Children asked medication questions
during 13% of visits (range, 0–6 ques-
tions; mean = 0.20; SD = 0.64). Providers
asked for child input into the asthma
management plan during only 7.8% of
the visits. Providers asked for caregiver
input into the asthmamanagement plan
during only 9% of the visits. Providers
asked questions about control medi-
cations during 66.8% of visits (range,
0–16 questions; mean = 2.4; SD = 2.9)
Adherence
Table 2 presents the distribution of
child- and caregiver-reported adher-
ence. Children reported an average con-
trol medication adherence for the week
before the home visit of 72.4% (SD = 32.9;
range, 0–100). Caregivers reported an
average child control medication ad-
herence for the week before the home
visit of 84.7% (SD = 26.1; range, 0–100).
The average child reported control
medication adherence was 12% lower
than the average caregiver-reported
adherence. However, caregiver- and
child-reported control medication ad-
herence were highly correlated (Pear-
son correlation = 0.64, P = .00).
Table 3 presents the GEE results pre-
dicting child-reported control medica-
tion adherence during the past week.
Children taking more than 1 control
medication reported being signifi-
cantly more adherent than children
taking just 1 control medication. Chil-
dren with higher asthma management
self-efficacy reported being signifi-
cantly more adherent than children
with lower asthma management self-
efficacy. Children with longer lengths
of visits were significantly more ad-
herent. The total number of control
medication questions the provider
asked during the visit was significantly
related to child-reported adherence in
the bivariate analysis (Pearson corre-
lation = 0.18, P = .01) but did not remain
significant in the adjusted GEE analysis.
Table 4 presents the GEE results pre-
dicting caregiver-reported child con-
trol medication adherence during the
past week. Caregivers reported sig-
nificantly higher adherence for youn-
ger children and children who had
higher asthmamanagement self-efficacy
scores. Caregivers reported signifi-
cantly higher child adherence if the
TABLE 1 Child and Caregiver Demographic
Characteristics (N = 259)
% (N)
Child age












Mild persistent 28.6 (74)
Moderate/severe persistent 71.4 (185)
Years living with asthma
Mean (SD), range 6.12 (3.9), 0–16 y
Caregiver age




Caregiver education in years















TABLE 2 Child and Caregiver Reported Control Medication Adherence Reported During the Past
Week
Reported Adherence Child (N = 216), % (N) Caregiver (N = 216), % (N)
0 8.8 (19) 2.8 (6)
1%–10% 0.5 (1) 0 (0)
11%–20% 1.9 (4) 2.8 (6)
21%–30% 5.1 (11) 1.9 (4)
31%–40% 0.9 (2) 0.9 (2)
41%–50% 5.6 (12) 0.9 (2)
51%–60% 6.9 (15) 4.6 (10)
61%–70% 5.6 (12) 2.3 (5)
71%–80% 5.1 (11) 6.0 (13)
81%–90% 11.6 (25) 7.4 (16)
91%–99% 11.1 (24) 7.9 (17)
100% 32.9 (71) 47.2 (102)
Missing 4.2 (9) 15.3 (33)
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provider asked for the caregiver’s in-
put into the asthma treatment plan
during the medical visit. Caregivers
reported lower child adherence if
the provider asked for child input into
the asthma treatment plan during the
medical visit.
DISCUSSION
When controlling for important de-
mographic characteristics and baseline
medication adherence, we found that
provider-patient communication during
a medical visit was associated with
caregiver-reported child medication ad-
herence 1month later.We also found that
child asthma management self-efficacy
was significantly associated with both
child- and caregiver-reported control
medicationadherence.Self-efficacy is1of
the key constructs in social cognitive
theory.13 According to social cognitive
theory, individuals with higher levels
of self-efficacy to perform a certain be-
havior such as using medications are
more likely to undertake the behavior.14,15
This finding suggests it is important
for health care providers to work with
children and caregivers to improve their
self-efficacy or self-confidence in man-
aging their asthma. One way providers
can improve asthma management self-
efficacy is to model positive medication
behaviors. For example, if children or
their caregivers have smart phones,
providers could show them how to use
a medication reminder application.
Another important finding is that if
providersasked forcaregiver input into
their child’s asthma management treat-
ment plan, caregivers reported higher
child medication adherence 1 month
later. This finding suggests it is impor-
tant for providers to ask for caregiver
input into their child’s asthma manage-
ment treatment plan because it might
be easier for them to follow a plan for
which they have had input. In fact,
the National Heart, Lung, and Blood In-
stitute guidelines3 specifically empha-
size teaching patients how to effectively
manage their asthma as well as the
importance of using a collaborative
approach between providers, parents,
and children to develop an appropriate
asthmamanagement plan for the child.
Research has revealed the importance
of patient-centeredapproaches suchas
SDM.4–6 However, we found that chil-
dren were only asked for their input
into treatment plans during 7.8% of
visits and that parents were asked for
their input during only 9% of visits.
These low rates of SDM occurred
even though providers were aware
that the medical visit was being re-
corded to examine communication
during pediatric asthma visits. A recent
study revealed that SDM increased
adherence to controller medications
and better clinical outcomes for adult
asthma patients as opposed to clini-
cian decision-making.6 These findings
support the importance of identify-
ing patient preferences and goals
to shape treatment plans. Future re-
search should examine how to improve
SDM during pediatric asthma visits.
Another interesting finding was that
caregivers reported lower child ad-
herence at the home visit if the provider
asked for child input during the medi-
cal visit that occurred ∼1 month ear-
lier. Child age was not significantly
TABLE 3 GEE Predicting Child Reported Control Medication Adherence During the Past Week at
the Home Visit (N = 165)
Independent Variables b Coefficient (95% Confidence Interval)
Child-reported medication adherence at office visit 0.22 (0.08 to 0.36)**
Years living with asthma 20.47 (21.61 to 0.66)
Child asthma severity 4.96 (24.20 to 14.12)
Child taking .1 controller medication 7.87 (0.26 to 15.48)*
Child age 20.64 (22.47 to 1.19)
Child gender 3.23 (24.55 to 11.01)
Child race 27.85 (219.36 to 3.66)
Caregiver education (in years) 21.09 (22.99 to 0.80)
Child asthma management self-efficacy 9.36 (2.32 to 16.39)**
Number of asthma medication questions the child asks 23.70 (212.62 to 5.21)
Provider asked for child input into asthma treatment plan 22.53 (216.20 to 11.13)
Provider asked for caregiver input into asthma treatment plan 4.87 (25.87 to 15.60)
Number of control medication questions the provider asks 0.49 (20.69 to 1.67)
Child asthma outcome expectations 0.35 (23.53 to 4.23)
Length of visit 0.01 (0.00 to 0.02)*
*P , .05; ** P , .01.
TABLE 4 GEE Predicting Caregiver Reported Control Medication Adherence During the Past Week
at the Home Visit (N = 158)
Independent Variables b Coefficient (95% Confidence Interval)
Parent-reported child medication adherence at office visit 0.09 (20.02 to 0.21)
Years living with asthma 20.28 (21.02 to 0.45)
Child asthma severity 3.02 (24.75 to 10.80)
Child taking .1 controller medication 1.37 (24.93 to 7.67)
Child age 21.69 (23.04 to 20.34)*
Child gender 0.77 (26.13 to 7.67)
Child race 0.21 (26.99 to 7.34)
Caregiver education (in years) 20.50 (21.77 to 0.76)
Child asthma management self-efficacy 18.92 (12.72 to 25.12)***
Number of asthma medication questions the child asks 21.90 (28.77 to 4.98)
Provider asked for child input into asthma treatment plan 28.82 (216.76 to 20.87)**
Provider asked for caregiver input into asthma treatment plan 9.01 (3.65 to 14.37)***
Number of control medication questions the provider asks 0.20 (21.03 to 1.43)
Child asthma outcome expectations 1.40 (22.16 to 4.96)
Length of visit 0.01 (20.01 to 0.02)
*P , .05; ** P , .01; *** P , .001.
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associated with whether providers
asked for child input into the treatment
regimen. Future research should de-
termine whether this result can be
replicated in other asthma populations.
Children taking more than 1 control
medication reportedbeing significantly
more adherent than children taking 1
control medication. A previous study
revealed that teenagers were more
willing to take medications when they
felt ill.6 Because children taking more
than 1 control medication may experi-
ence more symptoms when not taking
their medications, they may be more
likely to adhere. Further research
should explore this relationship to
better understand patient adherence.
Caregivers reported that younger chil-
dren were more adherent to their
control medications than older chil-
dren. This might be because caregivers
are more actively involved in helping
younger children take their control
medications than older children. Pro-
viders should make sure to talk with
older children directly about their
control medication adherence to as-
sess possible barriers to using them
and to offer suggestions on how to
improve adherence. Previous research
has revealed nonadherence to be
greatest among older children and
adolescents due to 2 factors, including
more risk-takingbehaviors andonset of
depressive symptoms.6 Additionally,
teenagers have reported that concerns
with side effects, busy schedules, spend-
ing nights away from home, and the
bad taste of inhaled corticosteroids
can interfere with adherence. Thus,
providers may want to engage older
adolescent children in discussions of
barriers to adherence.
Children and caregiver adherencewere
highly correlated, yet children reported
an average adherence rate of 72% for
the past week, and caregivers reported
an average adherence rate of 85%.
Previous research has revealed that
both children and parents greatly over
report their adherence to asthma
medications.16,17 In 1 study comparing
self-reported adherence to electron-
ic devices attached to participants’
metered-dose inhalers, both caregivers
and children significantly overreported
their adherence.16 The study revealed
that parents were more likely to be
outside the 25% accuracy range when
compared with children. Although we
cannot confirm whether child or care-
giver reports of adherence are more
accurate, our results suggest that
children’s adherence to asthma control
medications is suboptimal.
The study is limited in generalizability
in that it was conducted in 5 pediatric
clinics in nonurban areas of North
Carolina. Another limitation is that we
do not know how many patients who
the clinic staff referred chose not to
talk with the research assistant.
However, we could not ask the clinic
staff to track these numbers because
of the busyness of the clinic and our
promise not to interrupt clinic flow.
Another limitation is that we chose to
audio-tape rather than video-tape the
medical visits because it is less in-
trusive and fewer individuals mind
being audio-taped as opposed to being
video-taped. Additionally, we relied on
child and caregiver self-reported con-
trol medication adherence, and the
caregivers and children most likely
overreported their adherence, which is
often found with self-report measures.
Overestimating adherence likely biased
our results toward the null, making it
more difficult to find significant asso-
ciations between communication and
adherence. Despite the limitations of
the study, it presents new information
on how provider-patient communica-
tion about asthma during pediatric
visits from actual audio-taped visits is
associated with child- and caregiver-
reported adherence 1 month later.
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MANAGING CLUTTER: My wife and I recently spent six nights in California. We
spent the first three nights in a delightful small boutique hotel and the second
three in a hotel run by a large chain. While we loved the boutique hotel, the chain
hotel was almost as wonderful but for remarkably different reasons. The reason
we liked the second room so much was that it was large, simply furnished (al-
most Spartan) and totally devoid of paper and clutter. My wife is perfect in most
ways but has trouble parting with papers or anything our children have ever
touched. I tease her that she can cover any surface and that, as the papers pile
up, we will run out of room. According to an article in The Wall Street Journal
(Health & Wellness: July 10, 2012), clutter is a common source of friction in
a marriage—as common as issues related to sex or money. If the couple has very
different views of clutter, the stress (whether from the clutter itself or trying to fix
the problem) can undermine the relationship. Both men and women are equally
likely to have clutter and certain household hotspots are common. For example,
the foyer or entranceway may become a dumping ground for all sorts of stuff.
Piles of books and magazines often dominate the living room. Kitchen counters,
and almost all horizontal surfaces, are magnets for papers, gadgets, and things
that might be useful in the near future. Bathrooms are often filled with various
lotions, creams, soaps, and shampoos. Conquering clutter is not easy as the
discussion can lead to a struggle over power, control, or priorities of family life.
Handling differing views on clutter takes humor, patience, and understanding. As
for me, I have accepted shoveling out the mudroom now and then and the piles of
papers here and there. I insist in keeping one flat surface (the kitchen island) free
of extraneous materials. When the amount of clutter build-up gets really bad, we
go on vacation.
Noted by WVR, MD
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